Investors: AQSE Growth Market Apex Rulebook Rule 4.14 & Documents


Description of the business
Please click on Investors for a description of the business.
Last updated: 01 September 2020

The names of the directors and biographical details
Please click on Board & Management for the names of the directors and brief biographical details of each.
Last updated: 25 August 2020

Directors' responsibilities
Please click on Corporate Governance for a description (by title) of Directors' responsibilities.
Last updated: 01 September 2020

Board Committees
Please click on Corporate Governance for information on the Audit and Remuneration Committees together with the membership of those committees.
Last updated: 01 September 2020

Country of incorporation and main country of operation
Rutherford Health plc is incorporated in England & Wales (Registration Number: 09420705), and its main country of operation is the United Kingdom.
Last updated: 19 August 2019

Current constitutional documents
Please click on Articles of Association and Memorandum of Association for the Articles of Association and Memorandum.
Last updated: 25 August 2020

Details of any other exchanges or trading platforms
The Company is listed on the AQSE Growth Market (Apex Segment), it is not listed on any other exchanges or trading platforms.
Last updated: 20 May 2021

Number of securities in issue
Number of securities in issue: 198,011,700
Percentage of securities that are in public hands: 37.8%
Total Voting Rights: 198,011,700
Please click on Substantial Shareholders for further details.
Last updated: 29 January 2021

Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Last updated: 25 February 2019

Financial information and circulars to shareholders
Please click on Reports & Presentations for access to the Company's annual and interim reports, and circulars to shareholders.
Last updated: 25 August 2020

Company announcements
Please click on Announcements to access notifications.
Last updated: 23 March 2021

Admission document
Please click on Admission Document to access the Company's Admission Document.
Last updated: 25 February 2019

Advisors
Please click on Corporate Profile for details of the Company’s AQSE Corporate Adviser and other key advisers.
Last updated: 01 February 2021